Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AIM ImmunoTech (AIM) Other Non-Current Liabilities (2018 - 2025)

Historic Other Non-Current Liabilities for ImmunoTech (AIM) over the last 9 years, with Q3 2025 value amounting to $7.3 million.

  • ImmunoTech's Other Non-Current Liabilities changed N/A to $7.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.3 million, marking a year-over-year change of. This contributed to the annual value of $57000.0 for FY2019, which is 9462.77% down from last year.
  • ImmunoTech's Other Non-Current Liabilities amounted to $7.3 million in Q3 2025.
  • ImmunoTech's 5-year Other Non-Current Liabilities high stood at $7.3 million for Q3 2025, and its period low was $7.3 million during Q3 2025.